BG Medicine, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP - March 12, 2010

Attached files

file filename
S-1/A - FORM S-1 AMENDMENT NO.2 - BG Medicine, Inc.ds1a.htm
EX-10.8 - PARTICIPATION AGREEMENT - BG Medicine, Inc.dex108.htm
EX-10.7 - RESEARCH AND COLLABORATION AGREEMENT - BG Medicine, Inc.dex107.htm
EX-10.9 - PARTICIPATION AGEEMENT - BG Medicine, Inc.dex109.htm
EX-10.11 - PARTICIAPTION AGREEMENT - BG Medicine, Inc.dex1011.htm
EX-10.13 - SUPPLY AGREEMENT - BG Medicine, Inc.dex1013.htm
EX-10.10 - PARTICIPATION AGEEMENT - BG Medicine, Inc.dex1010.htm
EX-10.12 - PARTICIPATION AGREEMENT - BG Medicine, Inc.dex1012.htm
EX-10.4.1 - FIRST AMENDMENT TO LICENSE AND DISTRIBUTION AGREEMENT - BG Medicine, Inc.dex1041.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment No. 2 to Registration Statement No. 333-164574 of our report dated January 28, 2010 relating to the consolidated financial statements of BG Medicine, Inc. and subsidiary (which report expresses an unqualified opinion and includes an explanatory paragraph relating to substantial doubt about the company’s ability to continue as a going concern) appearing in the Prospectus, which is part of such Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

March 12, 2010    

BG Medicine, Inc. Reports